Immunobiological role of llama heavy-chain antibodies against a bacterial beta-lactamase
- PMID: 17448545
- DOI: 10.1016/j.vetimm.2007.03.003
Immunobiological role of llama heavy-chain antibodies against a bacterial beta-lactamase
Abstract
In 1993, a fraction of antibodies (Abs) devoid of L chain was found naturally occurring in the Camelidae. They were found to lack L chains, as well as the first constant heavy-chain domain (CH(1)) and therefore they were named "heavy-chain Abs" (HCAbs). Subsequent studies focused on the functional, structural and biochemical properties of recombinant variable fragments (rVHHs) of HCAbs. It was stated that rVHHs have an augmented capacity to interact with "partially hidden" epitopes, like enzymes active sites, and have an increased stability to thermal and chemical aggression. It has been suggested that these unconventional Abs could represent an evolutionary advantage, being more efficient than conventional Abs to inhibit microbial enzymes, and thus exerting a more protective immune response against pathogens. The present work focuses on the immunobiological role of HCAbs, in their capacity to inhibit microbial enzymes. Two animal models were selected, comprising a model for common vertebrates without HCAbs (rabbits), and a model for vertebrates with both conventional and unconventional Abs (Lama glama). A recombinant bacterial beta-lactamase (CTX-M-2) was selected as the microbial enzymatic antigen. After conventional immunization schedules, neither serum titers nor serum inhibitory capacity showed significant differences when rabbits and llamas were compared. These results indicate that the a priori assumption that the adaptive immune system of camelids could be better "prepared" to respond to bacterial enzymes because of the presence of HCAbs, is not always accurate. Furthermore, when the different llama antibody isotypes and subclasses were purified, it was demonstrated that the inhibitory capacity of total serum was due exclusively to IgG(1). HCAbs not only failed to inhibit CTX-M-2, but instead they activated its enzymatic activity. Altogether, these results indicate that the hypotheses extrapolated from the rVHHs properties need to be revised; the real role of HCAbs in vivo remains unknown, as well as their evolutionary cause.
Similar articles
-
Activity modulation of microbial enzymes by llama (Lama glama) heavy-chain polyclonal antibodies during in vivo immune responses.Animal. 2012 Mar;6(3):510-7. doi: 10.1017/S1751731111001789. Animal. 2012. PMID: 22436231
-
Structural analysis of effector functions related motifs, complement activation and hemagglutinating activities in Lama glama heavy chain antibodies.Vet Immunol Immunopathol. 2012 Jan 15;145(1-2):323-31. doi: 10.1016/j.vetimm.2011.12.001. Epub 2011 Dec 8. Vet Immunol Immunopathol. 2012. PMID: 22197565
-
Development of ELISAs for the measurement of IgM and IgG subclasses in sera from llamas (Lama glama) and assessment of the humoral immune response against different antigens.Vet Immunol Immunopathol. 2008 Nov 15;126(1-2):64-73. doi: 10.1016/j.vetimm.2008.06.015. Epub 2008 Jul 5. Vet Immunol Immunopathol. 2008. PMID: 18692907
-
Introduction to heavy chain antibodies and derived Nanobodies.Methods Mol Biol. 2012;911:15-26. doi: 10.1007/978-1-61779-968-6_2. Methods Mol Biol. 2012. PMID: 22886243 Review.
-
Nanobodies: natural single-domain antibodies.Annu Rev Biochem. 2013;82:775-97. doi: 10.1146/annurev-biochem-063011-092449. Epub 2013 Mar 13. Annu Rev Biochem. 2013. PMID: 23495938 Review.
Cited by
-
Evaluation of antidiphtheria toxin nanobodies.Nanotechnol Sci Appl. 2010 Jun 17;3:29-35. doi: 10.2147/nsa.s9591. eCollection 2010. Nanotechnol Sci Appl. 2010. PMID: 24198468 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources